GoodRx Holdings (GDRX): which funds own it

Who owns GoodRx Holdings?

Holders that filed a Schedule 13D or 13G with the SEC for owning more than 5% of the shares: Francisco Partners GP IV (13D/A filed Mar 18, 2025), Francisco Partners GP IV (13D/A filed Aug 26, 2026), Idea Men (13D/A filed Mar 21, 2025) and SEA VII Management (13D/A filed Sep 8, 2025). Spectrum VII Co-Investment Fund, L.P. and Spectrum Equity VII, L.P. are listed on their Form 4 filings as owners of more than 10%. As of Jun 30, 2026, the largest holders reported on Form 13F were Francisco Partners Management (60.1 million shares), LSV Asset Management (5.2 million shares) and Ameriprise Financial (4.7 million shares).

Sources:13D/A by Francisco Partners GP IV (Mar 18, 2025) ↗13D/A by Francisco Partners GP IV (Aug 26, 2026) ↗13D/A by Idea Men (Mar 21, 2025) ↗13D/A by SEA VII Management (Sep 8, 2025) ↗All of the company's proxy statements on EDGAR ↗

With more than one share class, a 13D or 13G counts shares convertible from another class as owned, so we do not show its percentage. We hold 13D and 13G filings made since Dec 23, 2024: a holder above 5% that has not filed since then does not appear here.

• Francisco Partners Management60.1 MPrivate equity or venture capital0
• LSV Asset Management5.2 MQuant or multi-manager+175 K
• Ameriprise Financial4.7 MWealth adviser+291 K
• Vanguard Capital Management4.1 MIndex manager−175 K
• Silver Lake Group, L.L.C3.5 MPrivate equity or venture capital0
• Renaissance Technologies3.2 MQuant or multi-manager−14 K
• Vanguard Portfolio Management3.2 MIndex manager−155 K
• Petrus Trust Company, LTA3.1 MWealth adviser0
• Dimensional Fund Advisors2.6 MIndex manager+109 K
• AQR Capital Management2.3 MQuant or multi-manager+524 K

The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.

Shares outstanding: buybacks and dilution

From the statements the company filed with the SEC (10-K). The change compares average diluted shares of each fiscal year, on today's basis: negative = it bought back more than it issued; positive = dilution. “No data” = the company does not report that item under a tag we can read; it does not mean zero.

Earnings quality and debt

From the figures the company filed with the SEC. Cash flow over net income near or above 1 means earnings are collected in cash; far below, that part is accounting. Coverage says how many times operating income pays the latest fiscal year's interest. Maturities come from the debt note of the latest annual report, counted from its closing date. “No data” never means zero.

Above 5% over time (13D/13G)

Each holder with its filings in order. History since December 2024.

Flagged material events (8-K)

• Nov 2, 2026Seriousfiling ↗

  Previously issued financial statements can no longer be relied on (Item 4.02)

• Mar 18, 2026Mediumfiling ↗

  Change of auditor (Item 4.01)

• Aug 5, 2026Routinefiling ↗

  Change in directors or officers (Item 5.02)

• Apr 24, 2026Routinefiling ↗

  Change in directors or officers (Item 5.02)

• Apr 3, 2026Routinefiling ↗

  Change in directors or officers (Item 5.02)

• Mar 27, 2026Routinefiling ↗

  Change in directors or officers (Item 5.02)

• Mar 6, 2026Routinefiling ↗

  Change in directors or officers (Item 5.02)

• Feb 27, 2026Routinefiling ↗

  Change in directors or officers (Item 5.02)

Alert items the company itself flagged in its 8-K filings with the SEC, most serious first. It is the form's label, with no interpretation from us: Item 5.02 covers routine appointments as well as a chief executive's departure; open the filing. The quoted headline is the original press release's.